Remimazolam for anesthesia in gynecological surgery
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests a sedative called remimazolam for women undergoing gynecological surgeries like hysterectomy or fibroid removal. The goal is to see how it works and if it's a good option for anesthesia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 64 years old
- Have a BMI between 18 and 30
- Be classified as ASA I or II (generally healthy or with mild disease)
- Be scheduled for a gynecological surgery like hysterectomy or fibroid removal
- Not be allergic to remimazolam or similar sedatives
- Not have serious heart, liver, kidney, or lung disease, or uncontrolled high blood pressure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new sedative called remimazolam for people having planned heart surgery with a heart-lung machine. It aims to see if it works well and is safe for keeping you asleep during the operation.
This trial tests whether a sedation drug called remimazolam can reduce the risk of severe low oxygen levels during a hysteroscopy for overweight or obese women undergoing fertility treatment. If you qualify, you may receive a gentler sedation option that could be safer for you.
This trial tests a sedative called remimazolam for people who need a high-risk ERCP procedure (a scope exam of the bile ducts). It is looking at whether remimazolam can provide safe and effective sedation for patients with serious health problems.
This trial tests whether the anesthesia medicine remimazolam can improve recovery and longer-term outcomes after surgery for early-stage bladder cancer. If you are having a bladder tumor procedure through the urethra, this study may help doctors understand whether this anesthesia choice matters for prognosis.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This trial tests if remimazolam, a sedative, can reduce low oxygen levels during a procedure to collect eggs from the ovaries. It may be a safer option for people having this fertility treatment.
Hear when a new Gynecological Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.